Intersect ENT, Inc
XENT
XENT was delisted on the 12th of May, 2022.
125 hedge funds and large institutions have $518M invested in Intersect ENT, Inc in 2015 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 64 increasing their positions, 21 reducing their positions, and 30 closing their positions.
205% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 21
0% less capital invested
Capital invested by funds: $520M → $518M (-$2.19M)
7% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 30
2% less funds holding
Funds holding: 128 → 125 (-3)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$24.3M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$20.6M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$17.2M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
+$10.4M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$10.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NVPX
Norwest Venture Partners XI
Palo Alto,
California
|
-$17.2M |
| 2 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$10.4M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$9.59M |
| 4 |
Millennium Management
New York
|
-$7.76M |
| 5 |
SAM
Senzar Asset Management
New York
|
-$6.69M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
OCM
151
Osterweis Capital Management
San Francisco,
California
| – | -$204K | -7,122 | Closed |
|
152
VOYA Investment Management
Atlanta,
Georgia
| – | -$201K | -7,029 | Closed |
|
|
QT
153
Quantbot Technologies
New York
| – | -$87K | -3,069 | Closed |
|
|
SAM
154
Sectoral Asset Management
Montreal,
Quebec, Canada
| – | -$9K | -320 | Closed |
|
|
LTFS
155
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | +$635 | +23 | New |
|
XENT Hedge Fund Activity: Q3 2015 in Review
125 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q3 2015, worth a combined $518M — down 0.42% from $520M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of XENT and 28 opened new positions — a net loss of 2 holders — while 21 trimmed existing stakes and 64 added.
The largest buyer was State Street, adding an estimated $24.3M. The largest seller was Norwest Venture Partners XI, exiting entirely with an estimated $17.2M sold.
- 125 institutional investors held Intersect ENT, Inc (XENT) as of Q3 2015, down from 128 in Q2 2015.
- Funds reported $518M of Intersect ENT, Inc stock for Q3 2015, down 0.42% quarter-over-quarter.
- 28 funds opened new Intersect ENT, Inc positions in Q3 2015 and 30 closed out, a net change of -2 holders.
- The largest Intersect ENT, Inc buyer in Q3 2015 was State Street, an estimated $24.3M added.
- The largest Intersect ENT, Inc seller in Q3 2015 was Norwest Venture Partners XI, an estimated $17.2M sold.
Based on aggregated 13F filings for Q3 2015.